https://www.selleckchem.com/pr....oducts/disodium-Crom
Main controversies in endometrial cancer treatment include the role of lymphadenectomy and optimal adjuvant treatment. We assessed clinical outcome in a population-based endometrial cancer cohort in relation to changes in treatment management over two decades. All consenting endometrial cancer patients receiving primary treatment at Haukeland University Hospital from 2001 to 2019 were included (n=1308). Clinicopathological variables were evaluated for year-to-year changes. Clinical outcome before and after discontinuing ad